Hyporesponsiveness to Re-challenge Dose Following Pneumococcal Polysaccharide Vaccine at 12 Months of Age, a Randomized Controlled Trial

BACKGROUND: To evaluate the immunological impact of the 23-valent pneumococcal polysaccharide vaccine (23vPPS) at 12 months, for children who have received zero to three infant doses of seven-valent pneumococcal conjugate vaccine (PCV), on responses to a subsequent exposure to a small dose of 23vPPS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Russell, FM, Carapetis, JR, Balloch, A, Licciardi, PV, Jenney, AWJ, Tikoduadua, L, Waqatakirewa, L, Pryor, J, Nelson, J, Byrnes, GB, Cheung, YB, Tang, MLK, Mulholland, EK
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2854305/
https://ncbi.nlm.nih.gov/pubmed/20206670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2010.02.087
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados